Senior CRA II – Remote/On-Site Clinical Monitoring

Syneos Health, Inc.; Amsterdam; On-site; EUR 27,000 - 41,000; Full time

Job summary

Syneos Health, Inc. is seeking a CRA II to oversee monitoring visits across Poland, ensuring regulatory compliance and data integrity. Responsibilities include site initiation, monitoring, and close-out, with remote and on-site activities as needed.

The role requires strong communication skills, knowledge of ICH/GCP guidelines, and the ability to manage travel up to 75%. Collaboration with cross-functional teams is essential to drive trial success.

Qualifications

• Excellent communication, presentation and interpersonal skills.
• Knowledge of Good Clinical Practice/ICH Guidelines and other applicable regulatory requirements.

Responsibilities

• Performs site qualification, site initiation, interim monitoring, site management activities and close-out visits (performed on-site or remotely).
• Verifies informed consent processes and protects patient confidentiality.
• Conducts source document review and data verification in CRFs, guiding query resolution to closure.
• Manages IP inventory, labeling, and storage according to protocol and regulations.
• Maintains ISF accuracy, supports recruitment and tracking, and ensures audit readiness.
• Understands project scope, budgets, timelines, and communicates with sites to meet objectives.
• Acts as liaison with study site personnel and ensures training/compliance.
• Prepares Investigator Meetings and participates in sponsor meetings and trainings.

Skills

Excellent communication

Interpersonal skills

Education

Bachelor’s degree or RN in a related field

Job description

Syneos Health, Inc. is seeking a CRA II to oversee monitoring visits across Poland, ensuring regulatory compliance and data integrity. Responsibilities include site initiation, monitoring, and close-out, with remote and on-site activities as needed.

The role requires strong communication skills, knowledge of ICH/GCP guidelines, and the ability to manage travel up to 75%. Collaboration with cross-functional teams is essential to drive trial success.